111
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Development of a liposome-based formulation for vitamin K1 nebulization on the skin

, , , , &
Pages 1823-1832 | Published online: 10 Apr 2014

References

  • PaceELe VitamineMilanUlrico Hoepli Editore1949
  • da silva alContriRVJornadaDSPohlmannARGuterresSSVitamin K1-loaded lipid-core nanocapsules: physiochemical characterization and in vitro skin permeationSkin Res Technol2012191e223e23022672012
  • LouWWQuintanaATGeronemusRGGrossmanMCEffects of topical vitamin K and retinol on laser-induced purpura on nonlesional skinDermatol Surg1999251294294410594627
  • ElsonMLNachtSTreatment of a periorbital hyperpigmentation with topical vitamin K/vitamin ACosmet Dermatol19991227127
  • LeuSHaveyJWhiteLEAccelerated resolution of laser-induced bruising with topical 20% arnica: a rater-blinded randomized controlled trialBr J Dermatol201016355756320412090
  • ShahNSLazarusMCBugdodelRThe effects of topical vitamin K on bruising after laser treatmentJ Am Acad Dermatol200247224124412140470
  • OcvirkJManagement of cetuximab-induced skin toxicity with the prophylactic use of topical vitamin K1 creamRadiol Oncol201044256266
  • SegaertSVan CutsemEClinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitorsAnn Oncol2005161425143316012181
  • Van CutsemEKöhneCHHitreECetuximab and chemotherapy as initial treatment for metastatic colorectal cancerN Engl J Med20093601408141719339720
  • TanEHChanAEvidence-based treatment options for the management of skin toxicities associated with epidermal growth factor receptor inhibitorsAnn Pharmacother200943101658166619755624
  • LiTHPerez-SolerRSkin toxicities associated with epidermal growth factor receptor inhibitorsTarget Oncol20094210711919452131
  • TomkováHPospíškováMZábojníkováMPhytomenadione pre-treatment in EGFR inhibitor-induced folliculitisJ Eur Acad Dermatol Venereol201327451451922035385
  • FerreiraLSRamaldesGANunanEAFerreiraLAIn vitro skin permeation and retention of paromomycin from liposomes for topical treatment of the cutaneous leishmaniasisDrug Dev Ind Pharm200430328929615109028
  • PugliaCTrombettaDVenutiVSaijaABoninaFEvaluation of in-vivo topical anti-inflammatory activity of indometacin from liposomal vesiclesJ Pharm Pharmacol200456101225123215482636
  • RamónEAlonsoCCoderchLLiposomes as alternative vehicles for sun filter formulationsDrug Deliv2005122838815824033
  • KitagawaSKasamakiMEnhanced delivery of retinoic acid to skin by cationic liposomesChem Pharm Bull (Tokyo)200654224224416462074
  • GokceEHKorkmazETuncay-TanrıverdiSA comparative evaluation of coenzyme Q10-loaded liposomes and solid lipid nanoparticles as dermal antioxidant carriersInt J Nanomedicine201275109511723055723
  • RahimpourYHamishehkarHLiposomes in cosmeceuticsExpert Opin in Drug Deliv201294443455
  • StewartJCMAnal Biochem1959104106892980
  • GilletALecomteFHubertPDucatEEvrardBPielGSkin penetration behaviour of liposomes as a function of their compositionEur J Pharm Biopharm201179435321272638
  • LopesLBSperettaFFBentleyMVEnhancement of skin penetration of vitamin K using monoolein-based liquid crystalline systemsEur J Pharm Sci200732320921517900879
  • OrtizAArandaFJThe influence of vitamin K1 on the structure and phase behavior of model membrane systemsBiochim Biophys Acta19991418120622010209225
  • PietzykBHenschkeKDegradation of phosphatidylcholine in liposomes containing carboplatin in dependence on composition and storage conditionsInt J Pharm2000196221521810699721
  • GritMCrommelinDJChemical stability of liposomes: implications for their physical stabilityChem Phys Lipids1993641–33188242840
  • FukuzawaKDynamics of lipid peroxidation and antioxidion of alpha-tocopherol in membranesJ Nutr Sci Vitaminol (Tokyo)200854427328518797148
  • PierreMBDos Santos Miranda CostaILiposomal systems as drug delivery vehicles for dermal and transdermal applicationsArch Dermatol Res2011303960762121805180
  • OgisoTNiinakaNIwakiMMechanism for enhancement effect of lipid disperse system on percutaneous absorptionJ Pharm Sci199685157648926585
  • YokomizoYSagitaniHThe effects of phospholipids on the percutaneous penetration of indomethacin through the dorsal skin of guinea pig in vitro. 2. The effects of the hydrophobic group in phospholipids and a comparison with general enhancersJ Control Release1996423746
  • LeeWCTsaiTHPreparation and characterization of liposomal coenzyme Q10 for in vivo topical applicationInt J Pharm201016395(1–2)7883
  • BaschongWArtmannCHueglinDRoedingJDirect evidence for bioconversion of vitamin E acetate into vitamin E: an ex vivo study in viable human skinJ Cosmet Sci200152315516111413495
  • BerrocalMCBujanJGarcia-HonduvillaNComparison of the effects of dimyristoyl and soya phosphatidylcholine liposomes on human fibroblastsDrug Deliv20007374410895418